You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

MPN, unclassifiable

Showing 1 - 25 of 100
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Myelodysplastic/Myeloproliferative Tumor With Ring Sideroblasts and Thrombocytosis, Myelodysplastic/Myeloproliferative Tumor,

Recruiting
  • Myelodysplastic/Myeloproliferative Neoplasm With Ring Sideroblasts and Thrombocytosis
  • Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jan 6, 2023

MPN Podcast Pilot Study

Completed
  • Myeloproliferative Neoplasm, Unclassifiable
    • Phoenix, Arizona
      Arizona State University
    Mar 26, 2020

    Acute Myeloid Leukemia, Myeloproliferative Tumor, Myelodysplastic/Myeloproliferative Tumor Trial in Canada, United States

    Recruiting
    • Acute Myeloid Leukemia
    • +2 more
    • Birmingham, Alabama
    • +9 more
    Aug 30, 2021

    Primary Myelofibrosis, Polycythemia Vera, Essential Thrombocythemia Trial in Toronto (Observational)

    Recruiting
    • Primary Myelofibrosis
    • +9 more
    • Observational
    • Toronto, Ontario, Canada
      Princess Margaret Cancer Centre
    Apr 11, 2022

    Myelodysplastic/Myeloproliferative Tumor, Unclassifiable, Myelofibrosis Transformation in Essential Thrombocythemia,

    Recruiting
    • Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable
    • +3 more
    • Houston, Texas
      M D Anderson Cancer Center
    Aug 18, 2022

    Expression Pattern of HNRNPH1 and HNRNPK Genes in MPNs

    Not yet recruiting
    • Myeloproliferative Neoplasms (MPNs)
    • Reverse transcription-quantitative polymerase chain reaction (RT-qPCR)
    • (no location specified)
    Mar 24, 2023

    Epigenetic Age on Clinic-biological Presentation and Prognosis

    Not yet recruiting
    • Myeloproliferative Neoplasm
    • Assessment of the epigenetic age
    • Bordeaux, France
      CHU de Bordeaux, service Hématologie Biologique
    Aug 28, 2023

    Acute Myeloid Leukemia, Essential Thrombocythemia, Myelodysplastic Syndrome Trial in Seattle (Decitabine, Ruxolitinib,

    Recruiting
    • Acute Myeloid Leukemia
    • +8 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Aug 18, 2022

    Monocytes Sub-populations in Thrombosis Associated With

    Recruiting
    • Myeloproliferative Neoplasm
    • 1 additional tube of blood
    • Bordeaux, France
    • +4 more
    Nov 30, 2022

    Myeloproliferative Tumor, Secondary Leukemia Trial (Multiomic characterization, In vitro drug screening)

    Not yet recruiting
    • Myeloproliferative Neoplasm
    • Secondary Leukemia
    • Multiomic characterization
    • In vitro drug screening
    • (no location specified)
    Aug 28, 2023

    Clonal Cytopenia of Undetermined Significance, Essential Thrombocythemia, Myelodysplastic Syndrome Trial in Los Angeles

    Not yet recruiting
    • Clonal Cytopenia of Undetermined Significance
    • +4 more
    • Biospecimen Collection
    • +6 more
    • Los Angeles, California
    • +1 more
    Oct 4, 2023

    MDS/MPN Trial in Nanjing (Azacitidine (AZA) with Ruxolitinib)

    Recruiting
    • MDS/MPN
    • Azacitidine (AZA) with Ruxolitinib
    • Nanjing, Jiangsu, China
      The First Affiliated Hospital of Nanjing Medical University
    Apr 17, 2023

    Action of Interferon in Treatment of Myeloproliferative

    Recruiting
    • Myeloproliferative Neoplasm
      • Villejuif, Ile De France, France
        Inserm U1287
      Apr 28, 2023

      MDS, Myeloproliferative Tumor, Anemia Trial in Tampa (Luspatercept)

      Recruiting
      • Myelodysplastic Syndromes
      • +2 more
      • Tampa, Florida
        Moffitt Cancer Center
      Feb 16, 2023

      Thrombosis in Myeloproliferative Neoplasms

      Completed
      • Myeloproliferative Neoplasm
      • 2 additional tubes of blood
      • Angers, France
      • +23 more
      Aug 17, 2022

      Myeloproliferative Tumor Trial in Irvine (Diet intervention)

      Completed
      • Myeloproliferative Neoplasm
      • Diet intervention
      • Irvine, California
        University of California, Irvine
      Jun 16, 2022

      Myeloproliferative Tumor, MPN, Essential Thrombocythemia Trial in Orange (N-Acetylcysteine)

      Active, not recruiting
      • Myeloproliferative Neoplasm
      • +4 more
      • Orange, California
        Chao Family Comprehensive Cancer Center, University of Californi
      Jan 6, 2023

      Iron Deficiency Anemia Trial in Australia, Israel, Romania (KER-047)

      Recruiting
      • Iron Deficiency Anemia
      • Adelaide, South Australia, Australia
      • +8 more
      Jun 23, 2023

      Myeloproliferative Tumor, Polycythemia Vera, Essential Thrombocythemia Trial in Hong Kong

      Recruiting
      • Myeloproliferative Neoplasm
      • +7 more
        • Hong Kong, Hong Kong
          Department of Medicine, Queen Mary Hospital
        May 21, 2023

        Myelodysplastic/Myeloproliferative Tumors, Adult Trial in Suzhou (venetoclax combined with azacitidine)

        Enrolling by invitation
        • Myelodysplastic/Myeloproliferative Neoplasms
        • Adult
        • venetoclax combined with azacitidine
        • Suzhou, Jiangsu, China
          The First Affiliated Hospital of Soochow University, Jiangsu Ins
        Mar 7, 2022

        Myelodysplastic/Myeloproliferative Tumor, Steroid Refractory GVHD, Allogeneic Hematopoietic Cell Transplant Trial in Toronto

        Completed
        • Myelodysplastic/Myeloproliferative Neoplasm
        • +2 more
        • Decidual stromal cells (DSC)
        • Toronto, Ontario, Canada
          Princess Margaret Cancer Centre
        Jan 8, 2023

        Myeloproliferative Tumor Trial (BCR-ABL gene PCR)

        Unknown status
        • Myeloproliferative Neoplasm
        • BCR-ABL gene PCR
        • (no location specified)
        Mar 16, 2020

        Myeloproliferative Tumor, Optical Genome Mapping, Cytogenetics Trial in Amiens (Blood sample)

        Recruiting
        • Myeloproliferative Neoplasm
        • +4 more
        • Blood sample
        • Amiens, Picardie, France
          Centre Hospitalier Universitaire d'Amiens
        Jan 27, 2023

        MDS/MPN Trial in Nashville (ASTX727, Itacitinib)

        Recruiting
        • MDS/MPN
        • Nashville, Tennessee
          Vanderbilt-Ingram Cancer Center
        Jun 20, 2022

        Accelerated Phase MPN, Blast Phase MPN Trial (zelavespib)

        Withdrawn
        • Accelerated Phase MPN
        • Blast Phase MPN
        • (no location specified)
        Nov 4, 2022